227 related articles for article (PubMed ID: 9930978)
21. Factor VIIa modified in the 170 loop shows enhanced catalytic activity but does not change the zymogen-like property.
Soejima K; Mizuguchi J; Yuguchi M; Nakagaki T; Higashi S; Iwanaga S
J Biol Chem; 2001 May; 276(20):17229-35. PubMed ID: 11278475
[TBL] [Abstract][Full Text] [Related]
22. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
23. Current status on tissue factor activation of factor VIIa.
Persson E; Olsen OH
Thromb Res; 2010 Apr; 125 Suppl 1():S11-2. PubMed ID: 20153879
[TBL] [Abstract][Full Text] [Related]
24. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
[TBL] [Abstract][Full Text] [Related]
25. The role of phospholipids and the factor VII Gla-domain in the interaction of factor VII with tissue factor.
Wildgoose P; Jørgensen T; Komiyama Y; Nakagaki T; Pedersen A; Kisiel W
Thromb Haemost; 1992 Jun; 67(6):679-85. PubMed ID: 1509409
[TBL] [Abstract][Full Text] [Related]
26. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
28. The quest for Factor VIIa exosite inhibitors.
Amour A; Hutchinson J; Ruiz Avendaño AM; Ratcliffe S; Alvarez E; Martin J; Toomey JR; Senger S; Wolfendale M; Mooney C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):555-8. PubMed ID: 17511650
[TBL] [Abstract][Full Text] [Related]
29. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
30. Factor VIIa-tissue factor interactions: an evaluation using factor VII-factor IX chimeras.
Chang JY
Haemostasis; 1996; 26 Suppl 1():35-9. PubMed ID: 8904171
[TBL] [Abstract][Full Text] [Related]
31. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
32. Predicted solution structure of zymogen human coagulation FVII.
Perera L; Darden TA; Pedersen LG
J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the extracellular region of human tissue factor.
Harlos K; Martin DM; O'Brien DP; Jones EY; Stuart DI; Polikarpov I; Miller A; Tuddenham EG; Boys CW
Nature; 1994 Aug; 370(6491):662-6. PubMed ID: 8065454
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity.
Higashi S; Matsumoto N; Iwanaga S
J Biol Chem; 1996 Oct; 271(43):26569-74. PubMed ID: 8900128
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
Carlsson K; Persson E; Carlsson U; Svensson M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
[TBL] [Abstract][Full Text] [Related]
36. Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase.
Flachner B; Varga A; Szabó J; Barna L; Hajdú I; Gyimesi G; Závodszky P; Vas M
Biochemistry; 2005 Dec; 44(51):16853-65. PubMed ID: 16363799
[TBL] [Abstract][Full Text] [Related]
37. Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complex.
Kirchhofer D; Guha A; Nemerson Y; Konigsberg WH; Vilbois F; Chène C; Banner DW; D'Arcy A
Proteins; 1995 Aug; 22(4):419-25. PubMed ID: 7479715
[TBL] [Abstract][Full Text] [Related]
38. Identification of regions of bovine factor VII essential for binding to tissue factor.
Higashi S; Nishimura H; Aita K; Iwanaga S
J Biol Chem; 1994 Jul; 269(29):18891-8. PubMed ID: 8034645
[TBL] [Abstract][Full Text] [Related]
39. Extrinsic activation of human coagulation factors IX and X on the endothelial surface.
Bom VJ; van Hinsbergh VW; Reinalda-Poot HH; Mohanlal RW; Bertina RM
Thromb Haemost; 1991 Sep; 66(3):283-91. PubMed ID: 1745998
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of Thermus caldophilus GK24 beta-glycosidase: role of His119 in substrate binding and enzyme activity.
Oh EJ; Lee YJ; Chol JJ; Seo MS; Lee MS; Kim GA; Kwon ST
J Microbiol Biotechnol; 2008 Feb; 18(2):287-94. PubMed ID: 18309273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
